Hiroko Nakamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroko Nakamura has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Hiroshi Kimura
Department of Mechanical Engineering, School of Engineering, Tokai University, 4-1-1 Kitakaname, Hiratsuka 259-1292, Japan
10 shared publications - Kenta Shinha
Tokai University, Japan
6 shared publications - Laner Chen
Micro/Nano Technology Center, Tokai University, Hiratsuka 259-1292, Kanagawa, Japan
4 shared publications - Naokata Kutsuzawa
Micro/Nano Technology Center, Tokai University, Hiratsuka 259-1292, Kanagawa, Japan
4 shared publications - Hajime Miyashita
Graduate School of Science and Technology, Tokai University, 4-1-1 Kitakaname, Hiratsuka 259-1292, Kanagawa, Japan
2 shared publications - Jin Hong Yap
Department of Mechanical Engineering, School of Engineering, Tokai University, 4-1-1 Kitakaname, Hiratsuka 259-1292, Japan
2 shared publications
Latest Publications
- Open Access
- 14 July 2026
- Published by MDPI AG in Micromachines
- Vol. 17 (7) , 835
An Open-Access Dialysis Membrane-Integrated Microfluidic Device for Generating Drug Exposure Profiles Through Molecular-Weight-Dependent Transport
Conventional in vitro assays and many microphysiological systems struggle to generate time-dependent drug exposure profiles because medium replacement simultaneously removes or re-adds drugs in the culture compartment. Here, we developed an Open-access Dialysis Membrane-integrated Microfluidic Device (O-DMiMD) that uses molecular weight-dependent transport across a dialysis membrane to decouple nutrient supply from drug exposure control. The device comprises a cell culture compartment (CCC) and a donor compartment (DC) separated by a dialysis membrane. Transport functions were evaluated using Lucifer Yellow, FITC-dextran, and glucose, followed by drug-response studies using SN-38 and T-DM1 under different medium change conditions. Lucifer Yellow and glucose permeated through the dialysis membrane, whereas FITC-dextran was retained. DC medium change supplied glucose to the CCC and maintained A549/HepG2 co-culture proliferation comparably to direct CCC medium replacement. For SN-38, partial transport to the DC and retention in the CCC generated time-dependent exposure profiles; in A549/HepaRG co-culture, medium change conditions altered A549 viability. For T-DM1, conditions with or without re-addition to the CCC produced different SK-BR-3 responses, suggesting exposure-dependent effects for high-molecular-weight drugs. The O-DMiMD provides an open-access in vitro platform for evaluating drug responses under exposure profiles governed by molecular weights, protein binding, medium changes, and metabolic cell contexts.
- 14 July 2026
- Published by MDPI AG in Micromachines
- Vol. 17 (7) , 835
Open AccessAn Open-Access Dialysis Membrane-Integrated Microfluidic Device for Generating Drug Exposure Profiles Through Molecular-Weight-Dependent Transport
Conventional in vitro assays and many microphysiological systems struggle to generate time-dependent drug exposure profiles because medium replacement simultaneously removes or re-adds drugs in the culture compartment. Here, we developed an Open-access Dialysis Membrane-integrated Microfluidic Device (O-DMiMD) that uses molecular weight-dependent transport across a dialysis membrane to decouple nutrient supply from drug exposure control. The device comprises a cell culture compartment (CCC) and a donor compartment (DC) separated by a dialysis membrane. Transport functions were evaluated using Lucifer Yellow, FITC-dextran, and glucose, followed by drug-response studies using SN-38 and T-DM1 under different medium change conditions. Lucifer Yellow and glucose permeated through the dialysis membrane, whereas FITC-dextran was retained. DC medium change supplied glucose to the CCC and maintained A549/HepG2 co-culture proliferation comparably to direct CCC medium replacement. For SN-38, partial transport to the DC and retention in the CCC generated time-dependent exposure profiles; in A549/HepaRG co-culture, medium change conditions altered A549 viability. For T-DM1, conditions with or without re-addition to the CCC produced different SK-BR-3 responses, suggesting exposure-dependent effects for high-molecular-weight drugs. The O-DMiMD provides an open-access in vitro platform for evaluating drug responses under exposure profiles governed by molecular weights, protein binding, medium changes, and metabolic cell contexts.
- Open Access
- 2 October 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (10) , 663
Double-Layered Microphysiological System Made of Polyethylene Terephthalate with Trans-Epithelial Electrical Resistance Measurement Function for Uniform Detection Sensitivity
Microphysiological systems (MPSs) have emerged as alternatives to animal testing in drug development, following the FDA Modernization Act 2.0. Double-layer channel-type MPS chips with porous membranes are widely used for modeling various organs, including the intestines, blood–brain barrier, renal tubules, and lungs. However, these chips faced challenges owing to optical interference caused by light scattering from the porous membrane, which hinders cell observation. Trans-epithelial electrical resistance (TEER) measurement offers a non-invasive method for assessing barrier integrity in these chips. However, existing electrode-integrated MPS chips for TEER measurement have non-uniform current densities, leading to compromised measurement accuracy. Additionally, chips made from polydimethylsiloxane have been associated with drug absorption issues. This study developed an electrode-integrated MPS chip for TEER measurement with a uniform current distribution and minimal drug absorption. Through a finite element method simulation, electrode patterns were optimized and incorporated into a polyethylene terephthalate (PET)-based chip. The device was fabricated by laminating PET films, porous membranes, and patterned gold electrodes. The chip’s performance was evaluated using a perfused Caco-2 intestinal model. TEER levels increased and peaked on day 5 when cells formed a monolayer, and then they decreased with the development of villi-like structures. Concurrently, capacitance increased, indicating microvilli formation. Exposure to staurosporine resulted in a dose-dependent reduction in TEER, which was validated by immunostaining, indicating a disruption of the tight junction. This study presents a TEER measurement MPS platform with a uniform current density and reduced drug absorption, thereby enhancing TEER measurement reliability. This system effectively monitors barrier integrity and drug responses, demonstrating its potential for non-animal drug-testing applications.
- 2 October 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (10) , 663
Open AccessDouble-Layered Microphysiological System Made of Polyethylene Terephthalate with Trans-Epithelial Electrical Resistance Measurement Function for Uniform Detection Sensitivity
Microphysiological systems (MPSs) have emerged as alternatives to animal testing in drug development, following the FDA Modernization Act 2.0. Double-layer channel-type MPS chips with porous membranes are widely used for modeling various organs, including the intestines, blood–brain barrier, renal tubules, and lungs. However, these chips faced challenges owing to optical interference caused by light scattering from the porous membrane, which hinders cell observation. Trans-epithelial electrical resistance (TEER) measurement offers a non-invasive method for assessing barrier integrity in these chips. However, existing electrode-integrated MPS chips for TEER measurement have non-uniform current densities, leading to compromised measurement accuracy. Additionally, chips made from polydimethylsiloxane have been associated with drug absorption issues. This study developed an electrode-integrated MPS chip for TEER measurement with a uniform current distribution and minimal drug absorption. Through a finite element method simulation, electrode patterns were optimized and incorporated into a polyethylene terephthalate (PET)-based chip. The device was fabricated by laminating PET films, porous membranes, and patterned gold electrodes. The chip’s performance was evaluated using a perfused Caco-2 intestinal model. TEER levels increased and peaked on day 5 when cells formed a monolayer, and then they decreased with the development of villi-like structures. Concurrently, capacitance increased, indicating microvilli formation. Exposure to staurosporine resulted in a dose-dependent reduction in TEER, which was validated by immunostaining, indicating a disruption of the tight junction. This study presents a TEER measurement MPS platform with a uniform current density and reduced drug absorption, thereby enhancing TEER measurement reliability. This system effectively monitors barrier integrity and drug responses, demonstrating its potential for non-animal drug-testing applications.
- Open Access
- 15 September 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (9) , 1051
The Fluidic Shear Stress Loading Method Enables Mechanobiological Stimulation in an On-Chip Pump-Integrated Microphysiological System
Microphysiological systems (MPSs), such as organ-on-a-chip platforms, are promising alternatives to animal testing for drug development and physiological research. The BioStellar™ Plate is a commercial MPS platform featuring an open-top culture chamber design with on-chip stirrer pumps that circulate culture medium through six independent, dual microchannel-connected chamber multiorgan units. Although this design enables a circular flow, the open-top culture chamber format prevents the application of fluidic shear stress, a force that cells experience in vivo, which affects their behavior and function. To address this, we developed two fluidic shear stress attachments for the BioStellar™ Plate. These attachment channel fluids provide controlled mechanical stimulation to cultured cells. The flow dynamics were simulated using COMSOL Multiphysics to estimate shear stress levels. The attachments were fabricated and validated through fluorescent bead tracking and biological assays. The FSSA-D is designed for flat-bottom standard cell cultures, while the FSSA-I is designed for epithelial monolayers, enabling the application of fluidic shear stress across the basal membrane. Experiments with intestinal epithelial cells (Caco-2) demonstrated that both attachments enhanced cell barrier function under a fluidic environment, as indicated by higher transepithelial electrical resistance (TEER). These findings demonstrate that the attachments are practical tools for mechanobiology research with MPS platforms.
- 15 September 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (9) , 1051
Open AccessThe Fluidic Shear Stress Loading Method Enables Mechanobiological Stimulation in an On-Chip Pump-Integrated Microphysiological System
Microphysiological systems (MPSs), such as organ-on-a-chip platforms, are promising alternatives to animal testing for drug development and physiological research. The BioStellar™ Plate is a commercial MPS platform featuring an open-top culture chamber design with on-chip stirrer pumps that circulate culture medium through six independent, dual microchannel-connected chamber multiorgan units. Although this design enables a circular flow, the open-top culture chamber format prevents the application of fluidic shear stress, a force that cells experience in vivo, which affects their behavior and function. To address this, we developed two fluidic shear stress attachments for the BioStellar™ Plate. These attachment channel fluids provide controlled mechanical stimulation to cultured cells. The flow dynamics were simulated using COMSOL Multiphysics to estimate shear stress levels. The attachments were fabricated and validated through fluorescent bead tracking and biological assays. The FSSA-D is designed for flat-bottom standard cell cultures, while the FSSA-I is designed for epithelial monolayers, enabling the application of fluidic shear stress across the basal membrane. Experiments with intestinal epithelial cells (Caco-2) demonstrated that both attachments enhanced cell barrier function under a fluidic environment, as indicated by higher transepithelial electrical resistance (TEER). These findings demonstrate that the attachments are practical tools for mechanobiology research with MPS platforms.
- Open Access
- 27 August 2025
- Published by MDPI AG in Preprints.org
Double-Layered Microphysiological System Made of Polyethylene Terephthalate with Trans-Epithelial Electrical Resistance Measurement Function for Uniform Detection Sensitivity
Microphysiological systems (MPS) have emerged as alternatives to animal testing in drug development, following the FDA Modernization Act 2.0. Double-layer channel-type MPS chips with porous membranes are versatile for modeling various organs, including the intestines, blood-brain barrier, renal tubules, and lungs. However, these chips faced challenges owing to optical interference caused by light scattering from the porous membrane, which hinders cell observation. One non-invasive method for assessing barrier integrity in these chips is trans-epithelial electrical resistance (TEER) measurement. Existing electrode-integrated MPS chips for TEER measurement have non-uniform current densities, leading to compromised measurement accuracy. Additionally, chips made from polydimethylsiloxane have been associated with drug absorption issues. This study developed an electrode-integrated MPS chip for TEER measurement with uniform current distribution and minimal drug absorption. Through finite element method simulation, electrode patterns were optimized and incorporated into a polyethylene terephthalate (PET)-based chip. The device was fabricated by laminating PET films, porous membranes, and patterned gold electrodes. The chip’s performance was evaluated using a perfused Caco-2 intestinal model. TEER levels peaked on day 5 when cells formed a monolayer, then decreased as villi-like structures developed. Capacitance increased, indicating microvilli formation. Exposure to staurosporine resulted in a dose-dependent reduction in TEER, which was validated by immunostaining indicating tight junction disruption. This study presents a TEER measurement MPS platform with uniform current density and reduced drug absorption, thereby enhancing TEER measurement reliability. This system effectively monitors barrier integrity and drug responses, demonstrating its potential for non-animal drug-testing applications.
- 27 August 2025
- Published by MDPI AG in Preprints.org
Open AccessDouble-Layered Microphysiological System Made of Polyethylene Terephthalate with Trans-Epithelial Electrical Resistance Measurement Function for Uniform Detection Sensitivity
Microphysiological systems (MPS) have emerged as alternatives to animal testing in drug development, following the FDA Modernization Act 2.0. Double-layer channel-type MPS chips with porous membranes are versatile for modeling various organs, including the intestines, blood-brain barrier, renal tubules, and lungs. However, these chips faced challenges owing to optical interference caused by light scattering from the porous membrane, which hinders cell observation. One non-invasive method for assessing barrier integrity in these chips is trans-epithelial electrical resistance (TEER) measurement. Existing electrode-integrated MPS chips for TEER measurement have non-uniform current densities, leading to compromised measurement accuracy. Additionally, chips made from polydimethylsiloxane have been associated with drug absorption issues. This study developed an electrode-integrated MPS chip for TEER measurement with uniform current distribution and minimal drug absorption. Through finite element method simulation, electrode patterns were optimized and incorporated into a polyethylene terephthalate (PET)-based chip. The device was fabricated by laminating PET films, porous membranes, and patterned gold electrodes. The chip’s performance was evaluated using a perfused Caco-2 intestinal model. TEER levels peaked on day 5 when cells formed a monolayer, then decreased as villi-like structures developed. Capacitance increased, indicating microvilli formation. Exposure to staurosporine resulted in a dose-dependent reduction in TEER, which was validated by immunostaining indicating tight junction disruption. This study presents a TEER measurement MPS platform with uniform current density and reduced drug absorption, thereby enhancing TEER measurement reliability. This system effectively monitors barrier integrity and drug responses, demonstrating its potential for non-animal drug-testing applications.
- Open Access
- 11 August 2025
- Published by MDPI AG in Preprints.org
Fluidic Shear Stress Loading Method Enables Mechanobiological Stimulation in An On-Chip Pump Integrated Microphysiological System
Microphysiological systems (MPS), such as organ-on-a-chip and body-on-a-chip platforms, have emerged as promising alternatives to animal testing for drug development and physiological research. The BioStellar™ Plate, an on-chip pump integrated microphysiological system, offers an open-access, multiorgan culture platform with built-in kinetic pump facilitating perfusion and circulation among six independent MO-MPS units. While effective in promoting convective flow, the current configuration cannot apply fluidic shear stress, an essential mechanical stimulus affecting cell behaviour and function, particularly in vascular, intestinal, and epithelial models. We developed two fluidic shear stress attachments for the BioStellar™ Plate to address this limitation. Flow dynamics were simulated using COMSOL Multiphysics to estimate shear stress levels within the system. The attachments were fabricated and validated through fluorescent bead tracking and biological assays. The flat-bottom Fluidic Shear Stress Attachment - Cell Desk (FSSA-D) is compatible with cell desk-based cultures. The Fluidic Shear Stress Attachment - Cell Culture Insert (FSSA-I) supports the culture of epithelial monolayers, enabling shear stress application across the basal membrane. Our results, including fluorescence imaging and TEER measurements, confirmed that both devices successfully enhanced barrier function under flow conditions. The reproducibility and consistent biological trends demonstrate the practicality of these attachments for mechanobiology research within MPS platforms.
- 11 August 2025
- Published by MDPI AG in Preprints.org
Open AccessFluidic Shear Stress Loading Method Enables Mechanobiological Stimulation in An On-Chip Pump Integrated Microphysiological System
Microphysiological systems (MPS), such as organ-on-a-chip and body-on-a-chip platforms, have emerged as promising alternatives to animal testing for drug development and physiological research. The BioStellar™ Plate, an on-chip pump integrated microphysiological system, offers an open-access, multiorgan culture platform with built-in kinetic pump facilitating perfusion and circulation among six independent MO-MPS units. While effective in promoting convective flow, the current configuration cannot apply fluidic shear stress, an essential mechanical stimulus affecting cell behaviour and function, particularly in vascular, intestinal, and epithelial models. We developed two fluidic shear stress attachments for the BioStellar™ Plate to address this limitation. Flow dynamics were simulated using COMSOL Multiphysics to estimate shear stress levels within the system. The attachments were fabricated and validated through fluorescent bead tracking and biological assays. The flat-bottom Fluidic Shear Stress Attachment - Cell Desk (FSSA-D) is compatible with cell desk-based cultures. The Fluidic Shear Stress Attachment - Cell Culture Insert (FSSA-I) supports the culture of epithelial monolayers, enabling shear stress application across the basal membrane. Our results, including fluorescence imaging and TEER measurements, confirmed that both devices successfully enhanced barrier function under flow conditions. The reproducibility and consistent biological trends demonstrate the practicality of these attachments for mechanobiology research within MPS platforms.
- Open Access
- 25 June 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (7) , 745
A Dialysis Membrane-Integrated Microfluidic Device for Controlled Drug Retention and Nutrient Supply
Traditional pre-clinical drug evaluation methods, including animal experiments and static cell cultures using human-derived cells, face critical limitations such as interspecies differences, ethical concerns, and poor physiological relevance. More recently, microphysiological systems (MPSs) that use microfluidic devices to mimic in vivo conditions have emerged as promising platforms. By enabling perfusion cell culture and incorporating human-derived cells, MPSs can evaluate drug efficacy and toxicity in a more human-relevant manner. However, standard MPS protocols rely on discrete medium changes, causing abrupt changes in drug concentrations that do not reflect the continuous pharmacokinetics seen in vivo. To overcome this limitation, we developed a Dialysis Membrane-integrated Microfluidic Device (DMiMD) which maintains continuous drug concentrations through selective medium change via a dialysis membrane. The membrane’s molecular weight cut-off (MWCO) enables the retention of high-molecular-weight drugs while facilitating the passage of essential low-molecular-weight nutrients such as glucose. We validated the membrane’s molecular selectivity and confirmed effective nutrient supply using cells. Additionally, anticancer drug efficacy was evaluated under continuously changing drug concentrations, demonstrating that the DMiMD successfully mimics in vivo drug exposure dynamics. These results indicate that the DMiMD offers a robust in vitro platform for accurate assessment of drug efficacy and toxicity, bridging the gap between conventional static assays and the physiological complexities of the human body.
- 25 June 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (7) , 745
Open AccessA Dialysis Membrane-Integrated Microfluidic Device for Controlled Drug Retention and Nutrient Supply
Traditional pre-clinical drug evaluation methods, including animal experiments and static cell cultures using human-derived cells, face critical limitations such as interspecies differences, ethical concerns, and poor physiological relevance. More recently, microphysiological systems (MPSs) that use microfluidic devices to mimic in vivo conditions have emerged as promising platforms. By enabling perfusion cell culture and incorporating human-derived cells, MPSs can evaluate drug efficacy and toxicity in a more human-relevant manner. However, standard MPS protocols rely on discrete medium changes, causing abrupt changes in drug concentrations that do not reflect the continuous pharmacokinetics seen in vivo. To overcome this limitation, we developed a Dialysis Membrane-integrated Microfluidic Device (DMiMD) which maintains continuous drug concentrations through selective medium change via a dialysis membrane. The membrane’s molecular weight cut-off (MWCO) enables the retention of high-molecular-weight drugs while facilitating the passage of essential low-molecular-weight nutrients such as glucose. We validated the membrane’s molecular selectivity and confirmed effective nutrient supply using cells. Additionally, anticancer drug efficacy was evaluated under continuously changing drug concentrations, demonstrating that the DMiMD successfully mimics in vivo drug exposure dynamics. These results indicate that the DMiMD offers a robust in vitro platform for accurate assessment of drug efficacy and toxicity, bridging the gap between conventional static assays and the physiological complexities of the human body.
- Open Access
- 11 May 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (5) , 307
A Microfluidic Device Integrating a Glucose Sensor and Calibration Function for Cell-Based Assays
Microphysiological systems (MPS) incorporating microfluidic technologies offer improved physiological relevance and real-time analysis for cell-based assays, but often lack non-invasive monitoring capabilities. Addressing this gap, we developed a microfluidic cell-based assay platform integrating an electrochemical biosensor for real-time, non-invasive monitoring of kinetic cell status through glucose consumption. The platform addresses the critical limitations of traditional cell assays, which typically rely on invasive, discontinuous methods. By combining enzyme-modified platinum electrodes within a microfluidic device, our biosensor can quantify dynamic changes in glucose concentration resulting from cellular metabolism. We have integrated a calibration function that corrects sensor drift, ensuring accurate and prolonged short-term measurement stability. In the validation experiments, the system successfully monitored glucose levels continuously for 20 h, demonstrating robust sensor performance and reliable glucose concentration predictions. Furthermore, in the cell toxicity assays using HepG2 cells exposed to varying concentrations of paraquat, the platform detected changes in glucose consumption, effectively quantifying the cellular toxicity responses. This capability highlights the device’s potential for accurately assessing the dynamic physiological conditions of the cells. Overall, our integrated platform significantly enhances cell-based assays by enabling continuous, quantitative, and non-destructive analysis, positioning it as a valuable tool for future drug development and biomedical research.
- 11 May 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (5) , 307
Open AccessA Microfluidic Device Integrating a Glucose Sensor and Calibration Function for Cell-Based Assays
Microphysiological systems (MPS) incorporating microfluidic technologies offer improved physiological relevance and real-time analysis for cell-based assays, but often lack non-invasive monitoring capabilities. Addressing this gap, we developed a microfluidic cell-based assay platform integrating an electrochemical biosensor for real-time, non-invasive monitoring of kinetic cell status through glucose consumption. The platform addresses the critical limitations of traditional cell assays, which typically rely on invasive, discontinuous methods. By combining enzyme-modified platinum electrodes within a microfluidic device, our biosensor can quantify dynamic changes in glucose concentration resulting from cellular metabolism. We have integrated a calibration function that corrects sensor drift, ensuring accurate and prolonged short-term measurement stability. In the validation experiments, the system successfully monitored glucose levels continuously for 20 h, demonstrating robust sensor performance and reliable glucose concentration predictions. Furthermore, in the cell toxicity assays using HepG2 cells exposed to varying concentrations of paraquat, the platform detected changes in glucose consumption, effectively quantifying the cellular toxicity responses. This capability highlights the device’s potential for accurately assessing the dynamic physiological conditions of the cells. Overall, our integrated platform significantly enhances cell-based assays by enabling continuous, quantitative, and non-destructive analysis, positioning it as a valuable tool for future drug development and biomedical research.
- Open Access
- 8 April 2025
- Published by MDPI AG in Preprints.org
A Microfluidic Device Integrating a Glucose Sensor and Calibration Function for Cell-Based Assays
Microphysiological systems (MPS) incorporating microfluidic technologies offer improved physiological relevance and real-time analysis for cell-based assays, but often lack non-invasive monitoring capabilities. Addressing this gap, we developed a microfluidic cell-based assay platform integrating an electrochemical biosensor for real-time, non-invasive monitoring of kinetic cell status through glucose consumption. The platform addresses the critical limitations of traditional cell assays, which typically rely on invasive, discontinuous methods. By combining enzyme-modified platinum electrodes within a microfluidic device, our biosensor can quantify dynamic changes in glucose concentration resulting from cellular metabolism. We have integrated a calibration function that corrects sensor drift, ensuring accurate and long-term measurement stability. In validation experiments, the system successfully monitored glucose levels continuously for 20 h, demonstrating robust sensor performance and reliable glucose concentration predictions. Furthermore, in cell toxicity assays using HepG2 cells exposed to varying concentrations of paraquat, the platform detected changes in glucose consumption, effectively quantifying cellular toxicity responses. This capability highlights the device's potential for accurately assessing the dynamic physiological conditions of cells. Overall, our integrated platform significantly enhances cell-based assays by enabling continuous, quantitative, and non-destructive analysis, positioning it as a valuable tool for future drug development and biomedical research.
- 8 April 2025
- Published by MDPI AG in Preprints.org
Open AccessA Microfluidic Device Integrating a Glucose Sensor and Calibration Function for Cell-Based Assays
Microphysiological systems (MPS) incorporating microfluidic technologies offer improved physiological relevance and real-time analysis for cell-based assays, but often lack non-invasive monitoring capabilities. Addressing this gap, we developed a microfluidic cell-based assay platform integrating an electrochemical biosensor for real-time, non-invasive monitoring of kinetic cell status through glucose consumption. The platform addresses the critical limitations of traditional cell assays, which typically rely on invasive, discontinuous methods. By combining enzyme-modified platinum electrodes within a microfluidic device, our biosensor can quantify dynamic changes in glucose concentration resulting from cellular metabolism. We have integrated a calibration function that corrects sensor drift, ensuring accurate and long-term measurement stability. In validation experiments, the system successfully monitored glucose levels continuously for 20 h, demonstrating robust sensor performance and reliable glucose concentration predictions. Furthermore, in cell toxicity assays using HepG2 cells exposed to varying concentrations of paraquat, the platform detected changes in glucose consumption, effectively quantifying cellular toxicity responses. This capability highlights the device's potential for accurately assessing the dynamic physiological conditions of cells. Overall, our integrated platform significantly enhances cell-based assays by enabling continuous, quantitative, and non-destructive analysis, positioning it as a valuable tool for future drug development and biomedical research.
- Open Access
- 12 March 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (3) , 327
Evaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Assisted Morphological Analysis
In recent years, microphysiological systems (MPS) using microfluidic technology as a new in vitro experimental system have shown promise as an alternative to animal experiments in the development of drugs, especially in the field of drug discovery, and some reports have indicated that MPS experiments have the potential to be a valuable tool to obtain outcomes comparable to those of animal experiments. We have commercialized the Fluid3D-X®, a double-layer microfluidic chip made of polyethylene terephthalate (PET), under the Japan Agency for Medical Research and Development (AMED) MPS development research project and have applied it to various organ models. When intestinal epithelial cells, Caco-2, were cultured using Fluid3D-X® and a peristaltic pump, villi-like structures were formed in the microchannels. Still, the degree of formation differed between the upstream and downstream sides. To examine the consideration points regarding the effects of the nutrient and oxygen supply by the chip material and the medium perfusion rate and direction on cells in the widely used double-layer microfluidic chip and to demonstrate the usefulness of a new imaging evaluation method using artificial intelligence technology as an assistive tool for the morphological evaluation of cells, the cell morphology in the channels was quantified and evaluated using the Nikon NIS.ai and microscopic observation. Villi-like structures were predominant upstream of the top channel, independent of the medium perfusion on the bottom channel, and those structures downstream developed with an increased flow rate. Additionally, compared to the Fluid3D-X®, the chip made of PDMS showed almost uniform villi-like sterilization in the channel. The result indicates that the environment within the microchannels differs because the amount of nutrients and oxygen supply varies depending on the medium’s perfusion and the material of the chips. As the amount of oxygen and nutrients required by different cell types differs, it is necessary to study the optimization of culture conditions according to the characteristics of the cells handled. It was also demonstrated that the AI-based image analysis method is helpful as a quantification method for the differences in cell morphology in the microchannel observed under a microscope.
- 12 March 2025
- Published by MDPI AG in Micromachines
- Vol. 16 (3) , 327
Open AccessEvaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Assisted Morphological Analysis
In recent years, microphysiological systems (MPS) using microfluidic technology as a new in vitro experimental system have shown promise as an alternative to animal experiments in the development of drugs, especially in the field of drug discovery, and some reports have indicated that MPS experiments have the potential to be a valuable tool to obtain outcomes comparable to those of animal experiments. We have commercialized the Fluid3D-X®, a double-layer microfluidic chip made of polyethylene terephthalate (PET), under the Japan Agency for Medical Research and Development (AMED) MPS development research project and have applied it to various organ models. When intestinal epithelial cells, Caco-2, were cultured using Fluid3D-X® and a peristaltic pump, villi-like structures were formed in the microchannels. Still, the degree of formation differed between the upstream and downstream sides. To examine the consideration points regarding the effects of the nutrient and oxygen supply by the chip material and the medium perfusion rate and direction on cells in the widely used double-layer microfluidic chip and to demonstrate the usefulness of a new imaging evaluation method using artificial intelligence technology as an assistive tool for the morphological evaluation of cells, the cell morphology in the channels was quantified and evaluated using the Nikon NIS.ai and microscopic observation. Villi-like structures were predominant upstream of the top channel, independent of the medium perfusion on the bottom channel, and those structures downstream developed with an increased flow rate. Additionally, compared to the Fluid3D-X®, the chip made of PDMS showed almost uniform villi-like sterilization in the channel. The result indicates that the environment within the microchannels differs because the amount of nutrients and oxygen supply varies depending on the medium’s perfusion and the material of the chips. As the amount of oxygen and nutrients required by different cell types differs, it is necessary to study the optimization of culture conditions according to the characteristics of the cells handled. It was also demonstrated that the AI-based image analysis method is helpful as a quantification method for the differences in cell morphology in the microchannel observed under a microscope.
- Open Access
- 17 February 2025
- Published by MDPI AG in Preprints.org
Evaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Based Morphological Analysis
Background: In recent years, microphysiological systems (MPS) using microfluidic technology as a new in vitro experimental system have shown promise as an alternative to animal experiments in the development of drugs, especially in the field of drug discovery, and reports have been published that MPS experiments have replaced animal experiments. We have commercialized the Fluid3D-X®, a double-layer microfluidic chip made of polyethylene terephthalate (PET), under the Japan Agency for Medical Research and Development (AMED) MPS development research project and have applied it to various organ models. When Caco-2 cells were cultured using Fluid3D-X® and a peristaltic pump, villi-like structures were formed in the microchannels, but the degree of formation differed between the upstream and downstream sides. To examine consideration points regarding the effects of the nutrient and oxygen supply by the chip material and medium flow on cells in the widely used double-layer microfluidic chip, and demonstrate the usefulness of a new imaging evaluation method using artificial intelligence technology for the morphological evaluation of cells. Methods: The following studies were conducted. 1. Perfusion direction: The medium was perfused at a normal flow rate (20 µL/min) using Fluid3D-X® and a peristaltic pump in opposite directions within the top and bottom channels and in the same direction initially, then reversed in both layers. 2. Perfusion speed: Incubated at normal and doubled (40 µL/min) flow rates using Fluid3D-X® and a peristaltic pump. 3. Materials: Incubated at the normal flow rate with Fluid3D-X® and polydimethylsiloxane (PDMS) chip, which has the same microchannel design as Fluid3D-X® but is made of PDMS. Results: Cell morphology in the channels was quantified and evaluated using Nikon NIS.ai in addition to microscopic observation. Villi-like structures were predominant upstream of the top channel, independent of perfusion on the bottom channel, and those structures downstream increased with doubled speed. Additionally, compared to the Fluid3D-X, the chip made of PDMS showed almost uniform villi-like sterilization in the channel. Conclusion: As the amount of oxygen and nutrients required by different cell types differs, it is necessary to study the optimization of culture conditions according to the characteristics of the cells handled.
- 17 February 2025
- Published by MDPI AG in Preprints.org
Open AccessEvaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Based Morphological Analysis
Background: In recent years, microphysiological systems (MPS) using microfluidic technology as a new in vitro experimental system have shown promise as an alternative to animal experiments in the development of drugs, especially in the field of drug discovery, and reports have been published that MPS experiments have replaced animal experiments. We have commercialized the Fluid3D-X®, a double-layer microfluidic chip made of polyethylene terephthalate (PET), under the Japan Agency for Medical Research and Development (AMED) MPS development research project and have applied it to various organ models. When Caco-2 cells were cultured using Fluid3D-X® and a peristaltic pump, villi-like structures were formed in the microchannels, but the degree of formation differed between the upstream and downstream sides. To examine consideration points regarding the effects of the nutrient and oxygen supply by the chip material and medium flow on cells in the widely used double-layer microfluidic chip, and demonstrate the usefulness of a new imaging evaluation method using artificial intelligence technology for the morphological evaluation of cells. Methods: The following studies were conducted. 1. Perfusion direction: The medium was perfused at a normal flow rate (20 µL/min) using Fluid3D-X® and a peristaltic pump in opposite directions within the top and bottom channels and in the same direction initially, then reversed in both layers. 2. Perfusion speed: Incubated at normal and doubled (40 µL/min) flow rates using Fluid3D-X® and a peristaltic pump. 3. Materials: Incubated at the normal flow rate with Fluid3D-X® and polydimethylsiloxane (PDMS) chip, which has the same microchannel design as Fluid3D-X® but is made of PDMS. Results: Cell morphology in the channels was quantified and evaluated using Nikon NIS.ai in addition to microscopic observation. Villi-like structures were predominant upstream of the top channel, independent of perfusion on the bottom channel, and those structures downstream increased with doubled speed. Additionally, compared to the Fluid3D-X, the chip made of PDMS showed almost uniform villi-like sterilization in the channel. Conclusion: As the amount of oxygen and nutrients required by different cell types differs, it is necessary to study the optimization of culture conditions according to the characteristics of the cells handled.